Biotechnology and Chemical Pharmaceutical Customer Partnership Meeting Tuesday, March 6, 2007 United States Patent and Trademark Office Alexandria, Virginia Madison Auditorium North The next meeting of the U.S. Patent and Trademark Office Biotechnology and Chemical Pharmaceutical Customer Partnership is scheduled for Tuesday, March 6, 2007 from 9:00 am to 4:30 pm. This meeting is also available on-line. Participation is limited to the first 200 individual registrants; so, if you are interested in attending this meeting, please click on the link below to register: On-Line Registration The most recent quarterly meeting for the Biotechnology and Chemical Pharmaceutical Customer Partnership was held on December 5, 2006 at the U.S. Patent and Trademark Office. The Biotechnology and Chemical Pharmaceutical Customer Partnership is designed and developed to be a forum to share ideas, experiences, and insights between individual users and the USPTO. The USPTO does not intend to use these customer partnership groups to arrive at any consensus. Invitations to participate will indicate that individual opinions are sought, rather than a group consensus and that the meetings are intended to be informal in nature and have varying participants. These customer partnership groups are formed with full recognition of the USPTO's responsibility under the Federal Advisory Committee Act (FACA), and that these customer partnership groups are not established as FACA compliant committees. We value our customers in obtaining feedback from individual participants as this is important in our efforts to continuously improve the quality of our products and services. Your willing participation to assist us is helpful in providing us with insights and experiences via this informal process. For information of future meetings and presentations, please go to http://www.cabic.com/bcp/. Please contact Cecilia Tsang at 571-272-0562, or by fax at 571-273-0562, or email Cecilia.Tsang@uspto.gov to decline or confirm your attendance by March 1, 2007.
Morning Session
9:00-9:05	Greetings and Overview	John LeGuyader, Bruce Kisliuk, George C. Elliott, Directors, Technology Center 1600
9:05-9:20	Complex Work Unit (CWU) Pilot – Chemcial & Mathematical Formulae, Large Tables and Protein Structure Data	Lisa Hobbs, SIRA
9:20-10:00	Appeals	Jean Witz, tQAS Appeals Technology Center 1600
10:00-10:40	Discussion of claim Types – Genus, Species, Linking, and Markush	Julie Burke, Special Programs Examiner Technology Center 1600
10:40-10:55	Break
10:45-12:00	Markush Notice of Proposed Rulemaking Preview	John LeGuyader, Director Technology Center 1600
12:00-1:15 Lunch
	Afternoon Session
1:15-2:00	Examination of Protein Crystallography Applications	Kathleen Bragdon , Supervisory Patent Examiner, Art Unit 1656
2:00-2:45	Immunology /Cancer Therapy	Gary Nickol, Supervisory Patent Examiner, Art Unit 1646
2:45-3:00	Break
3:00-3:45	Enablement Issues in Pharmaceutical Claims	Joseph McKane Supervisory Patent Examiner Art Unit 1626 and Ardin Marschel Supervisory Patent Examiner Art Unit,1614)
3:45-4:00	Closing Remarks/Discussion	John LeGuyader, Bruce Kisliuk, George C. Elliott, Directors, TC 1600

KEY: =online business system =fees =forms=help =laws/regulations =definition (glossary)

The Inventors Assistance Center is available to help you on patent matters.Send questions about USPTO programs and services to the USPTO Contact Center (UCC). You can suggest USPTO webpages or material you would like featured on this section by E-mail to the webmaster@uspto.gov. While we cannot promise to accommodate all requests, your suggestions will be considered and may lead to other improvements on the website.